Primo-Med, Methenolone Acetate, 25 mg, 120 Tabs

Methenolone Acetate 25 mg tablets by Bioniche Pharma are an orally active anabolic agent structurally distinguished from typical oral steroids by the absence of $17\alpha$-alkylation. Formulated by Bioniche Pharma for high target selectivity with low androgenic strength and zero estrogenic conversion, Bioniche Pharma Methenolone Acetate delivers effective tissue-building support without subjecting hepatic tissue to $17\alpha$-alkylated strain.

CLINICAL PHARMACOLOGY & DYNAMICS

Methenolone Acetate in Bioniche Pharma Methenolone Acetate interacts directly with intracellular androgen nuclear receptors, steering nitrogen balance into a positive state to accelerate cellular protein translation. By promoting tissue synthesis across skeletal muscle and bone matrix, Bioniche Pharma Methenolone Acetate aids in lean mass preservation and functional recovery during catabolic states.

INDICATIONS & CLINICAL USE

• Palliative management for postmenopausal female patients with advanced, hormone-sensitive breast carcinoma using Bioniche Pharma formulations.
• Therapeutic support during rehabilitation following severe trauma, major surgical interventions, or chronic debilitating wasting conditions under Bioniche Pharma care protocols.
• Adjunctive treatment in growth delay disorders under specialized endocrinological direction.

CONTRAINDICATIONS

• Male individuals with confirmed or suspected breast cancer.
• Female breast carcinoma complicated by severe hypercalcemia (elevated serum calcium levels).
• Confirmed or suspected carcinoma of the prostate gland in male patients.
• Severe hepatic failure or advanced renal impairment.
• Pregnancy and lactation due to serious risks of female fetal masculinization and endocrine disruption.

DOSAGE & ADMINISTRATION

Dosing protocols for Methenolone Acetate 25 mg by Bioniche Pharma should be individually calculated and monitored under direct clinical supervision, adjusted according to therapeutic goals, diagnostic laboratory findings, and patient tolerance.

ADVERSE REACTIONS & PRECAUTIONS

While Bioniche Pharma Methenolone Acetate is characterized by a low androgenic profile, androgen-mediated side effects can arise in predisposed or sensitive patients:

• Dermatological: Heightened sebum secretion (oily skin), acne vulgaris, and accelerated facial or body hair growth (hirsutism) linked to Bioniche Pharma Methenolone Acetate administration.
• Endocrine & Systemic: Reversible suppression of pituitary gonadotropin release at higher dosages, warranting regular hormonal profile evaluations during Bioniche Pharma treatment.

STORAGE & HANDLING

Store Bioniche Pharma Methenolone Acetate in a dry, cool environment protected from direct sunlight, elevated heat, and excess humidity. Keep strictly out of the reach and sight of children.